Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

AI improves medical care by enhancing diagnosis and treatment for better patient outcomes.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

N‐AOHPA is a promising alternative to traditional surfactants for better hair conditioning.

AMT® is effective and safe for early-stage knee osteoarthritis.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

No cure exists for alopecia areata, and treatments are personalized.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

The new AI system accurately diagnoses hair disorders and offers personalized treatment recommendations.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Alopecia areata significantly strains healthcare and finances in the UAE, needing better management.

Inflammatory diets may increase the risk and severity of alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

A certain gene variation can affect protein production and is linked to male pattern baldness.

AMPD is a better and less damaging alternative to ammonium hydroxide for hair bleaching.

CS12192 effectively treats alopecia areata with better safety than current options.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

The 2003 Australian Medicines Handbook was a clear, concise drug reference guide, updated with new topics and evidence, and considered essential for medical practice.